i-Base home
Search Menu
  • Home
  • HTB
  • 2009
  • October
  • 02

HTB

2 October 2009

Contents

Antiretrovirals

  • Etravirine (Intelence) label change in the US due to severe hypersensitivity reactions

PK and drug interactions

  • Raltegravir trough levels reduced by etravirine may require use of TDM
  • Lopinavir/r affects PK exposure of some antimalarial drugs
  • Darunavir/r increases exposure to nevirapine
  • Interaction between Ginkgo biloba and efavirenz
  • Use of raltegravir in HIV-positive transplant recipients

Basic science and immunology

  • Trends in Immunology: free access issue on immune senescence
  • Low viral loads in elite controllers
  • Immune surveillance below the radar: study offers explanation for acyclovir’s failure to reduce HIV risk
  • Low-level HIV replication versus latency: identifying the source of viral rebounds during treatment interruption

BHIVA news

  • Detention and removal of HIV-positive people in the UK

Correspondence

  • Letter: comment on swine flu algorithm

On the web

  • 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention abstracts
  • Access to HCV treatment in Eastern Europe
  • Guide to HIV and hepatitis B coinfection
  • TAG pipeline report
  • New TB website and resource
  • HIV and the kidneys
  • Video news: online resource
  • HTB RSS

Current issues

  • February 2021
  • January 2021
  • December 2020
  • Back issues

Special report

  • Early results report 90% efficacy with from Pfizer/BioNTech COVID vaccine 11 November 2020

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

This site complies with the HONcode standard for trustworthy health information.

Verify here.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
107 The Maltings, 169 Tower Bridge Road, London SE1 3LJ.
Tel + 44 (0) 208 616 2210. Email admin@i-base.org.uk
Registered charity no: 1081905. Company reg no: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Advocate
Professional
Donate
Feedback
Advice and information
Q and A
Phoneline
Pocket info
Guides
HIV meds
Glossary
Research and conference reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
News and updates
News
Blogs
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
Sitemap
Home
Find us on Facebook